The combination of Dasatinib and Quercetin (D + Q) for treating osteoporosis is currently being evaluated in clinical trial NCT04313634.

Authors

• Person: Not available Organization: Nature
  Cellular rejuvenation: molecular mechanisms and potential ... - Nature

Sources

• Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com Nature via serper

Referenced by nodes (1)

• Dasatinib concept